Citadel Advisors’s GenVec, Inc. GNVC Stock Holding History

Citadel Advisors’s Portfolio GNVC Stock Details GNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,248	Closed	-$10K	–	8056
2016 Q1	$10K	Buy	+1,248	New	+$8.36K	﹤0.01%	6601
2015 Q3	–	Sell	-1,558	Closed	-$32K	–	9761
2015 Q2	$32K	Sell	1,558 -203	-12%	-$4.95K	﹤0.01%	7928
2015 Q1	$52K	Buy	+1,761	New	+$57.9K	﹤0.01%	7364
2013 Q4	–	Sell	-1,946	Closed	-$25K	–	7538
2013 Q3	$25K	Buy	+1,946	New	+$10.6K	﹤0.01%	6125

Other funds holding GNVC

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citadel Advisors's GNVC Position: Q2 2016 in Review

Citadel Advisors sold out of GenVec, Inc. (GNVC) in Q2 2016, closing a stake of 1,248 shares — an estimated $10K sold.

Citadel Advisors first reported a position in GNVC in Q3 2013 and held it in 4 quarters. The position peaked at $52K in Q1 2015. 24 funds tracked by Wall St. Rank hold GNVC as of Q2 2016.

Citadel Advisors reported no remaining GenVec, Inc. position as of Q2 2016 after selling out during the quarter.
Citadel Advisors sold 1,248 GenVec, Inc. shares in Q2 2016, an estimated $10K.
Citadel Advisors first reported a position in GenVec, Inc. in Q3 2013 and held it in 4 quarters.
Citadel Advisors's GenVec, Inc. position peaked at $52K in Q1 2015.
24 funds tracked by Wall St. Rank held GenVec, Inc. as of Q2 2016.

Based on Citadel Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.